Inpixon Acquires Portfolio of GPS Technologies to Bridge the Market's Indoor-Outdoor Positioning Gap
01 juil. 2019 08h30 HE
|
Inpixon
PALO ALTO, Calif., July 01, 2019 (GLOBE NEWSWIRE) -- Inpixon (Nasdaq: INPX), a leading indoor positioning and data analytics company, today announced it has completed the acquisition and licensing...
DENMAT SUES VIAX TECHNOLOGIES FOR PATENT INFRINGEMENT
27 juin 2019 08h00 HE
|
Den-Mat Holdings, LLC.
Lompoc, CA, June 27, 2019 (GLOBE NEWSWIRE) -- DenMat Holdings, LLC (“DenMat”) a global leader in esthetic dental technology, announced today that it has filed a lawsuit for patent infringement...
Voip-Pal.com Files an Opposition to Apple and Amazon’s Motion to Dismiss; The Company Also Files its Appeal with the U.S. Court of Appeals for the Federal Circuit
26 juin 2019 05h00 HE
|
Voip-Pal.Com Inc.
BELLEVUE, Wash., June 26, 2019 (GLOBE NEWSWIRE) -- Voip-Pal.com Inc. (“Voip-Pal”, “Company”) (OTCQB: VPLM) announced two significant legal filings in support of its patent lawsuits. On June 19,...
Patent Services USA
25 juin 2019 19h44 HE
|
Patent Services USA
Miami, Florida, June 25, 2019 (GLOBE NEWSWIRE) -- Patent Services USA is pleased to announce its APP development and protection service. Through this service, innovative individuals will be able to...
Incysus Therapeutics Announces Publication of U.S. Patent for Drug Resistant Immunotherapy (DRI) Technology
19 juin 2019 08h00 HE
|
Incysus Therapeutics, Inc.
US Patent and Trademark Office Issues U.S. Patent Covering Drug Resistant Immunotherapy (DRI) TechnologyClaims Provide Initial Protection for Incysus’ Novel DRI PlatformIncysus Controls Exclusive...
IPBC Global 2019 Keynote Highlights Dolby’s Multigenerational Innovation, Ecosystem Engagement and Strategy Alignment
18 juin 2019 16h05 HE
|
Dolby Laboratories
BOSTON, June 18, 2019 (GLOBE NEWSWIRE) -- Dolby Laboratories Executive Vice President, General Counsel, and Corporate Secretary Andy Sherman delivered a keynote presentation entitled, “Dolby: 50...
Federal Court of Appeal Upholds I-MED Pharma’s Patent Win Against TearLab
17 juin 2019 11h05 HE
|
I-MED Pharma
MONTREAL, June 17, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the Canadian Federal Court of Appeal...
Yield10 Bioscience Files U.S. Patent Application Covering New Technology Enabling Low-cost Production of PHA-based Biomaterials in Camelina
17 juin 2019 08h30 HE
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 17, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Amarantus Announces Issuance of US Patent No. 10,195,251 Covering MANF Treatment of Wolfram's Syndrome, Retinitis Pigmentosa, and Glaucoma for Subsidiary MANF Therapeutics
13 juin 2019 08h42 HE
|
Amarantus Bioscience Holdings, Inc.
New York, NY, June 13, 2019 (GLOBE NEWSWIRE) -- via NEWEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding...
BioCardia Announces Issuance of Chinese Patent for Image-Guided Biotherapeutic Delivery
12 juin 2019 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced...